Registration and Informed Consent Study for the Childhood Cancer Research Network
NCT00433394 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2242
Last updated 2013-06-27
Summary
RATIONALE: Collecting informed consent from parents of children with cancer to register with the Childhood Cancer Research Network may help the study of cancer in the future.
PURPOSE: This study is collecting informed consent to register younger patients with cancer into the Childhood Cancer Research Network.
Conditions
- Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
- PROCEDURE
-
cancer prevention intervention
- PROCEDURE
-
educational intervention
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Children's Oncology Group
lead NETWORK
Principal Investigators
-
Julie A. Ross, PhD · Masonic Cancer Center, University of Minnesota
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-05-31
- Primary Completion
- 2007-01-31
- Completion
- 2011-01-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
NCT00919750 ·Status: COMPLETED
-
Evaluating Supportive Care for Children With Cancer: A Multi-Institutional Survey Study of Pediatric Oncology Patients and Parents
NCT01273194 ·Status: COMPLETED
-
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
NCT00001686 ·Status: COMPLETED
-
Project: Every Child for Younger Patients With Cancer
NCT02402244 ·Status: RECRUITING
-
Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors.
NCT03972514 ·Status: ACTIVE_NOT_RECRUITING
-
Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
NCT00024284 ·Status: COMPLETED ·Phase: PHASE1
-
Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants
NCT00008424 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
NCT00006095 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
NCT06942039 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors
NCT00003096 ·Status: COMPLETED
-
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
NCT04684368 ·Status: RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors
NCT00281944 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
NCT00674193 ·Status: COMPLETED
-
Infections in Pediatric Cancer Patients
NCT00930267 ·Status: UNKNOWN
-
Fenretinide in Treating Children With Solid Tumors
NCT00003191 ·Status: COMPLETED ·Phase: PHASE1
-
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
NCT00003597 ·Status: COMPLETED ·Phase: PHASE1
-
Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia
NCT00003933 ·Status: COMPLETED ·Phase: NA
-
Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors
NCT01858155 ·Status: COMPLETED ·Phase: PHASE1
-
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
NCT02847130 ·Status: COMPLETED
-
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
NCT00392886 ·Status: UNKNOWN ·Phase: PHASE3
-
Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas
NCT00165139 ·Status: COMPLETED ·Phase: PHASE2
-
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
NCT00890435 ·Status: COMPLETED
-
Irinotecan in Treating Children With Refractory Solid Tumors
NCT00004078 ·Status: COMPLETED ·Phase: PHASE2
-
Eligibility Screening for a NCI Pediatric Oncology Branch Research Study
NCT00026780 ·Status: COMPLETED
-
Study of Irinotecan on a Weekly Schedule in Children
NCT00062842 ·Status: COMPLETED ·Phase: PHASE1